<https://rdf.molmedb.upol.cz/reference/ref732> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495882>;
	<http://purl.org/dc/terms/bibliographicCitation> "Dong Z, Ekins S, Polli JE.: Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Mol Pharm, Volume 10 (3), 2013"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1021/mp300453k"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM16815>,
		<https://rdf.molmedb.upol.cz/transporter/target66>,
		<https://identifiers.org/molmedb/MM495882.1>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/pmid> "23339484"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra31999> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref732> .
<https://rdf.molmedb.upol.cz/transporter/tra32001> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref732> .